Sensitization by subcutaneous route is superior to intraperitoneal route in induction of asthma by house dust mite in a murine mode

Marcelo Vivolo Aun, Beatriz Mangueira Saraiva-Romanholo, Francine Maria de Almeida, Thayse Regina Brüggemann, Jorge Kalil, Milton de Arruda Martins, Fernanda Magalhães Arantes-Costa, Pedro Giavina-Bianchi, Marcelo Vivolo Aun, Beatriz Mangueira Saraiva-Romanholo, Francine Maria de Almeida, Thayse Regina Brüggemann, Jorge Kalil, Milton de Arruda Martins, Fernanda Magalhães Arantes-Costa, Pedro Giavina-Bianchi

Abstract

Objective: To develop a new experimental model of chronic allergic pulmonary disease induced by house dust mite, with marked production of specific immunoglobulin E (IgE), eosinophilic inflammatory infiltrate in the airways and remodeling, comparing two different routes of sensitization.

Methods: The protocol lasted 30 days. BALB/c mice were divided into six groups and were sensitized subcutaneously or intraperitoneally with saline (negative control), Dermatophagoides pteronyssinus (Der p) 50 or 500 mcg in three injections. Subsequently they underwent intranasal challenge with Der p or saline for 7 days and were sacrificed 24 hours after the last challenge. We evaluated the titration of specific IgE anti-Der p, eosinophilic density in peribronchovascular space and airway remodeling.

Results: Both animals sensitized intraperitoneally and subcutaneously produced specific IgE anti-Der p. Peribronchovascular eosinophilia increased only in mice receiving lower doses of Der p. However, only the group sensitized with Der p 50 mcg through subcutaneously route showed significant airway remodeling.

Conclusion: In this murine model of asthma, both pathways of sensitization led to the production of specific IgE and eosinophilia in the airways. However, only the subcutaneously route was able to induce remodeling. Furthermore, lower doses of Der p used in sensitization were better than higher ones, suggesting immune tolerance. Further studies are required to evaluate the efficacy of this model in the development of bronchial hyperresponsiveness, but it can already be replicated in experiments to create new therapeutic drugs or immunotherapeutic strategies.

Conflict of interest statement

Conflict of interest: none.

Figures

Figure 1. Diagram of the protocol for…
Figure 1. Diagram of the protocol for sensitization, challenge, and sacrifice with duration of 30 days (D0 to D29)
Figure 2. Values of mean ± standard…
Figure 2. Values of mean ± standard error of the titration of specific IgE anti-Dermatophagoides pteronyssinus by the passive cutaneous anaphylaxis technique
Figure 3. Values of mean ± standard…
Figure 3. Values of mean ± standard error of the titration of specific IgG1 anti-Dermatophagoides pteronyssinus by the immunoenzymatic assay technique (ELISA)
Figure 4. Values of mean ± standard…
Figure 4. Values of mean ± standard error of the eosinophilic density in the peribronchovascular space (hematoxylin-eosin). The density was determined by the count of number of eosinophils present in the inflammatory infiltrate, between the bronchus and the adjacent artery, divided by the number of points corresponding to the total area of the inflammatory infiltrate, with a 1000x magnification
Figure 5. Evaluation of airway remodeling by…
Figure 5. Evaluation of airway remodeling by the quantification of collagen fibers stained by Picrosirius. The collagen area (mean ± standard error) was expressed by a ratio of the area of the collagen fibers (in µm2) and the perimeter of the airway (in µm2)
Figura 1. Esquema do protocolo de sensibilização,…
Figura 1. Esquema do protocolo de sensibilização, provocação e sacrifício com duração de 30 dias (D0 a D29)
Figura 2. Valores de média ± erro…
Figura 2. Valores de média ± erro padrão da titulação da IgE específica anti-Dermatophagoides pteronyssinus pela técnica da passive cutaneous anaphylaxis
Figura 3. Valores de média ± erro…
Figura 3. Valores de média ± erro padrão da titulação da IgG1 específica anti- Dermatophagoides pteronyssinus pela técnica da ensaio imunoenzimático (ELISA)
Figura 4. Valores de média ± erro…
Figura 4. Valores de média ± erro padrão da densidade eosinofílica no espaço peribroncovascular (hematoxilina e eosina). A densidade foi determinada pela contagem do número de eosinófilos presentes no infiltrado inflamatório, entre o brônquio e a artéria adjacente, dividido pelo número de pontos correspondendo à área total do infiltrado inflamatório, num aumento de 1000x
Figura 5. Avaliação do remodelamento das vias…
Figura 5. Avaliação do remodelamento das vias aéreas pela quantificação de fibras colágenas coradas por Picrosirius. A área do colágeno (média ± erro padrão) foi expressa em uma relação entre a área das fibras colágenas (em µm2) e o perímetro da via aérea (em µm2)

References

    1. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143–178.
    1. Global iniciative for asthma . Global strategy for asthma management and prevention. Vancouver: GINA; 2014. [cited 2014 June 17]. Revised 2014 [Internet] .
    1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O’Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala AND, Valovirta AND, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka AND, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D, World Health Organization. GA(2)LEN. AllerGen Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy. 2008;63(Suppl 86):8–160. Review.
    1. Lourenço O, Fonseca AM, Taborda-Barata L. Demographic, laboratory and clinical characterisation of adult portuguese asthmatic patients. Allergol Immunopathol (Madr) 2007;35(5):177–183.
    1. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18(5):693–704. Review.
    1. Zosky GR, Sly PD. Animal models of asthma. Clin Exp Allergy. 2007;37(7):973–988. Review.
    1. Bates JH, Rincon M, Irvin CG. Animal models of asthma. Am J Physiol-Lung Cell Mol Physiol. 2009;297(3):L401–L410. Review.
    1. Conrad ML, Yildirim AO, Sonar SS, Kilic A, Sudowe S, Lunow M, et al. Comparison of adjuvant and adjuvant-free murine experimental asthma models. Clin Exp Allergy. 2009;39(8):1246–1254.
    1. Epstein MM. Do mouse models of allergic asthma mimic clinical disease? Int Arch Allergy Immunol. 2004;133(1):84–100. Review.
    1. Baqueiro T, Russo M, Silva VM, Meirelles T, Oliveira PR, Gomes E, et al. Respiratory allergy to Blomia tropicalis: Immune response in four syngeneic mouse strains and assessment of a low allergen-dose, short-term experimental model. Respir Res. 2010;11(51)
    1. Johnson JR, Wiley RE, Fattouh R, Swirski FK, Gajewska BU, Coyle AJ, et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med. 2004;169(3):378–385.
    1. Rigaux P, Daniel C, Hisbergues M, Muraille E, Hols P, Pot B, et al. Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy. Allergy. 2009;64(3):406–414.
    1. Ogawa H, Azuma M, Muto S, Nishioka Y, Honjo A, Tezuka T, et al. IκB kinase β inhibitor IMD-0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma. Clin Exp Allergy. 2011;41(1):104–115.
    1. Giavina-Bianchi P, Kalil J, Rizzo LV. Development of an animal model for allergic conjunctivitis: influence of genetic factors and allergen concentration on immune response. Acta Ophthalmol. 2008;86(6):670–675.
    1. Egito ES, Aiello VD, Bosisio IB, Lichtenfels AJ, Horta AL, Saldiva PH, et al. Vascular remodeling process in reversibility of pulmonary arterial hypertension secondary to congenital heart disease. Pathol Res Pract. 2003;199(8):521–532.
    1. Ovary Z. Passive cutaneous anaphylaxis in the mouse. J Immunol. 1958;81(4):355–357.
    1. Mota I, Wong D. Homologous and heterologous passive cutaneous anaphylactic activity of mouse antisera during couse of immunization. Life Sci. 1969;8(16):813–820.
    1. Braun A. Animal models of asthma. Curr Drug Targets. 2008;9(6):436–437.
    1. Platts-Mills TA, Vervloet D, Thomas WR, Aalberse RC, Chapman MD. Indoor allergens and asthma: report of the Third International Workshop. J Allergy Clin Immunol. 1997;100(6 Pt 1):S2–S24. Review.
    1. Kelada SN, Wilson MS, Tavarez U, Kubalanza K, Borate B, Whitehead GS, et al. Strain-dependent genomic factors affect allergen-induced airway hyperresponsiveness in mice. Am J Respir Cell Mol Biol. 2011;45(4):817–824.
    1. Clarke AH, Thomas WR, Rolland JM, Dow C, O’Brien RM. Murine allergic respiratory responses to the major house dust mite allergen Der p 1. Int Arch Allergy Immunol. 1999;120(2):126–134.
    1. Rodrigues AM, Schmidt CZ, Gualdi LP, Cao RG, Souza RG, Pereira AC, et al. Proposed short-term model of acute allergic response, without adjuvant use, in the lungs of mice. J Bras Pneumol. 2012;38(5):595–604. English, Portuguese.
    1. Holgate ST. Innate and adaptive immune responses in asthma. Nat Med. 2012;18(5):673–683. Review.
    1. Miike S, Kita H. Human eosinophils are activated by cysteine proteases and release inflammatory mediators. J Allergy Clin Immunol. 2003;111(4):704–713.

Source: PubMed

3
Abonnere